1. US says unlikely to use China, Russia COVID-19 vaccine as race heats up  CNA
  2. Fauci urges caution on China and Russia virus vaccines  Yahoo Singapore News
  3. US Says It Is Unlikely To Use China, Russia Coronavirus Vaccines  NDTV
  4. Fauci urges caution on China and Russia COVID-19 vaccines  CNA
  5. US urges caution on China, Russia Covid-19 vaccines  New Straits Times Online
  6. View Full coverage on Google News
America's top infectious diseases official has raised concerns over the safety of COVID-19 vaccines being developed by China and Russia as the ...America's top infectious diseases official has raised concerns over the safety of COVID-19 vaccines being developed by China and Russia as the ...

US says unlikely to use China, Russia COVID-19 vaccine as race heats up - CNA

America's top infectious diseases official has raised concerns over COVID-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades. Six months after the World Health Organization declared a global emergency, the novelAmerica's top infectious diseases official has raised concerns over COVID-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades. Six months after the World Health Organization declared a global emergency, the novel

US official cautions over China, Russia virus vaccines as race heats up

America's top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades. But US infectious disease expert Anthony Fauci said it was unlikely his country would use any vaccine developed in either country, where regulatory systems are far more opaque than they are in the West. "I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone," he told a US Congressional hearing on Friday. "Claims of having a vaccine ready to distribute before you do testing, I think, is problematic, at best."America's top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades. But US infectious disease expert Anthony Fauci said it was unlikely his country would use any vaccine developed in either country, where regulatory systems are far more opaque than they are in the West. "I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone," he told a US Congressional hearing on Friday. "Claims of having a vaccine ready to distribute before you do testing, I think, is problematic, at best."

Covid-19: US says unlikely to use China, Russia virus vaccine | International - Times of India Videos

Moderna had a head start in advancing its COVID-19 vaccine into clinical testing. But Pfizer is ahead in some important ways.Moderna had a head start in advancing its COVID-19 vaccine into clinical testing. But Pfizer is ahead in some important ways.

Why Pfizer Could Be a Bigger Coronavirus Winner Than Moderna | The Motley Fool

Chinese hackers targeted the biotech firm Moderna earlier this year, a company that announced a COVID-19 vaccine candidate in January. That's according to a U.S. security official who exclusively spoke to Reuters, who says the hackers were backed by Beijing. Moderna's vaccine candidate is one of the earliest and biggest bets by the Trump administration to fight the global pandemic. This comes after the Justice Department last week revealed an indictment against two Chinese nationals accused of spying. The indictment listed three targets based in the U.S. working on COVID-19 research, one of which was known to be working on a vaccine in January. Moderna confirmed to Reuters that it had been in contact with the FBI and was made aware of quote "information reconaissance activities" by the group in last week's indictment. The federal government is supporting development of the company's vaccine with nearly half a billion dollars -- and helping Moderna launch a clinical trial of up to 30,000 people beginning this month. China is also racing to develop a vaccine, bringing together its state, military and private sectors to combat a disease that has killed over 660,000 people worldwide. The Chinese government has consistently denied any role in hacking incidents across the globe. The spokesperson for China's embassy to the U.S. did not address specific questions sent by email. The two other medical companies mentioned in the indictment are firms based in California and Maryland, which would match Gilead Sciences and Novavax. Both companies declined to comment on specific cybersecurity matters.Chinese hackers targeted the biotech firm Moderna earlier this year, a company that announced a COVID-19 vaccine candidate in January. That's according to a U.S. security official who exclusively spoke to Reuters, who says the hackers were backed by Beijing. Moderna's vaccine candidate is one of the earliest and biggest bets by the Trump administration to fight the global pandemic. This comes after the Justice Department last week revealed an indictment against two Chinese nationals accused of spying. The indictment listed three targets based in the U.S. working on COVID-19 research, one of which was known to be working on a vaccine in January. Moderna confirmed to Reuters that it had been in contact with the FBI and was made aware of quote "information reconaissance activities" by the group in last week's indictment. The federal government is supporting development of the company's vaccine with nearly half a billion dollars -- and helping Moderna launch a clinical trial of up to 30,000 people beginning this month. China is also racing to develop a vaccine, bringing together its state, military and private sectors to combat a disease that has killed over 660,000 people worldwide. The Chinese government has consistently denied any role in hacking incidents across the globe. The spokesperson for China's embassy to the U.S. did not address specific questions sent by email. The two other medical companies mentioned in the indictment are firms based in California and Maryland, which would match Gilead Sciences and Novavax. Both companies declined to comment on specific cybersecurity matters.

Chinese hackers targeted vaccine firm Moderna [Video]

China provides Latin America access to Chinese COVID-19 vaccine - CGTN

WASHINGTON: America's top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades.WASHINGTON: America's top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades.

US wary of Chinese and Russian vaccines

Moderna Inc (NASDAQ: MRNA), which commenced a late-stage trial of its mRNA vaccine, codenamed mRNA-1273, against SARS-CoV-2 earlier in the week, has ...Moderna Inc (NASDAQ: MRNA), which commenced a late-stage trial of its mRNA vaccine, codenamed mRNA-1273, against SARS-CoV-2 earlier in the week, has been reportedly targeted...

Moderna, Inc. (MRNA) - Moderna Targeted By Chinese Hackers For Data Theft: Report | Benzinga

The World Health Organization chief scientist said any country supporting the COVAX financing initiative has a better chance of getting a Covid-19 vaccine.The World Health Organization chief scientist said any country supporting the COVAX financing initiative has a better chance of getting a Covid-19 vaccine.

U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine - STAT

Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, according to Dr. Anthony Fauci, which is the standard for vaccines.Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, ac…

This might be the best coronavirus vaccine news you’ve ever heard – BGR

Scientists and HIV/AIDS activists call on NIH and vaccine companies to change criteriaScientists and HIV/AIDS activists call on NIH and vaccine companies to change criteria

Groups protest exclusion of HIV-infected people from coronavirus vaccine trials | Science | AAAS

Public health officials say a promising coronavirus vaccine is on it's way in 2021. But does that matter if only half of Americans say they're willing to get such a vaccination?Public health officials say a promising coronavirus vaccine is on it's way in 2021. But does that matter if only half of Americans say they're willing to get such a vaccination?

Public Health Expert Calls To Repair Distrust In A COVID-19 Vaccine : Coronavirus Live Updates : NPR

A US says that the government in talks with private companies to build technology for monitoring COVID-19 vaccine deployment - according to Reuters reA US says that the government in talks with private companies to build technology for monitoring COVID-19 vaccine deployment - according to Reuters re

US official: Public will be ‘overwhelmed’ by government communications promoting covid-19 vaccines by November - Reuters

I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone, says Dr FauciI do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone, says Dr Fauci

US unlikely to use any COVID-19 vaccine developed by China, Russia

Shares of Moderna Inc. undefined were down 0.2% in trading on Thursday after the market closed when it said a board member had resigned to avoid the...Shares of Moderna Inc. undefined were down 0.2% in trading on Thursday after the market closed when it said a board member had resigned to avoid the...

Moderna board member resigns to prevent perception of conflict of interest in vaccine trial - MarketWatch

US states' "diversity of response" hampered the country's ability to contain the spread of the coronavirus, Dr. Anthony Fauci said at a Congressional hearing on Friday, as the number of cases in the US topped 4.5 million.

US coronavirus: 'Diversity of resopnse' hurt US ability to contain Covid-19

US top expert Anthony Fauci says regulatory systems in the countries are more opaque than they are in the WestUS top expert Anthony Fauci says regulatory systems in the countries are more opaque than they are in the West

US says will not use China, Russia vaccines - News | Khaleej Times

Anthony Fauci, the United States' top infectious disease official, has raised concerns about COVID-19 vaccines that are being developed by China and Russia. Recently, during a Congressional hearing, Fauci hinted that it would be unlikely for the US to use Russian or Chinese vaccines if they arrive first. "I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone," he said.Anthony Fauci, the United States' top infectious disease official, has raised concerns about COVID-19 vaccines that are being developed by China and Russia. Recently, during a Congressional hearing, Fauci hinted that it would be unlikely for the US to use Russian or Chinese vaccines if they arrive first. "I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone," he said.

Fauci concerned about proper testing for COVID-19 vaccines by Russia and China, World News | wionews.com

Live version of coronavirus map America's top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed byLive version of coronavirus map America’s top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles …

Concern over Covid-19 vaccines from Russia, China - Asia Times

The Boston hospital is participating in Moderna's trial for a COVID-19 vaccine.The Boston hospital is participating in Moderna's trial for a COVID-19 vaccine.

Brigham and Women's president resigns from Moderna's board

Dr. Fauci remains confident that a vaccine will be ready by early next year. Southwest is fed up with passengers bringing their own alcohol. More news.Dr. Fauci remains confident that a vaccine will be ready by early next year. Southwest is fed up with passengers bringing their own alcohol. More news.

COVID update: Fauci vaccine; Lena Dunham symptoms; St. Louis Cardinals

WASHINGTON (Reuters) -- Chinese government-linked hackers targeted biotech company Moderna Inc, a leading U.S.-based coronavirus vaccine research deveUS biotech firm's network allegedly probed by 'reconnaissance' activity

China-backed hackers targeted Moderna's COVID vaccine: report - Nikkei Asian Review

Human challenge trials and equitable distribution of vaccines were extensively discussed in this symposiumHuman challenge trials and equitable distribution of vaccines were extensively discussed in this symposium

Human Challenge Trial For COVID-19 Unnecessary: Anthony Fauci At ICMR Event

SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA | WOAI

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA

PORTSMOUTH – Lonza Biologics has begun what it describes as "small-scale" production of the COVID-19 vaccine from Moderna while the drug is in its phase 3 clinical trial.Lonza spokesperson Glenn Myers confirmed "we have started small-scale manufacturing," but he couldn’t divulge how much volume the company at Pease International Tradeport was producing at this point.He added that "each large-scale line will be able to produce around 100 million doses a year, based on a dosage ofPORTSMOUTH – Lonza Biologics has begun what it describes as "small-scale" production of the COVID-19 vaccine from Moderna while the drug is in its phase 3 clinical trial.Lonza spokesperson Glenn Myers confirmed "we have started small-scale manufacturing," but he couldn’t divulge how much volume the company at Pease International Tradeport was producing at this point.He added that "each large-scale line will be able to produce around 100 million doses a year, based on a dosage of

Lonza starts ‘small-scale’ production of coronavirus vaccine - News - fosters.com - Dover, NH

WASHINGTON: Anthony Fauci, the United States’ top infectious disease official, raised concerns on Friday regarding the safety of Covid-19 vaccines under development by China and Russia.

US urges caution on China, Russia Covid-19 vaccines | New Straits Times

The first round of people participating in a COVID-19 vaccine trial in South Texas were given a dose Thursday.The first round of people participating in a COVID-19 vaccine trial in South Texas were given a dose Thursday.

COVID-19 vaccine trial underway in South Texas

Coronavirus (COVID-19) Vaccine Tracker, Moderna, Oxford Vaccine Latest News Update: The vaccine being developed by Oxford University has just begun phase-III human trials, while the one by Johnson & Johnson is carrying out phase-I and phase-II trials.Coronavirus (COVID-19) vaccine tracker update: The vaccine being developed by Oxford University has just begun phase-III human trials, while the one by Johnson & Johnson is carrying out phase-I and phase-II trials.

Coronavirus (COVID-19) Vaccine Tracker Latest Update, 31 July: Oxford, Johnson & Johnson vaccines prevent infection in monkeys

Hackers backed by the Chinese government attempted to steal coronavirus vaccination data from US-based biotech company, Moderna Inc., a U.S. security official tracking Chinese hacking reveled in an exclusive Reuters report Friday.Hackers backed by the Chinese government attempted to steal coronavirus vaccination data from US-based biotech company, Moderna Inc., a U.S. security official tracking Chinese hacking reveled in an exclusive Reuters report Friday.

Moderna's vaccine candidate is one of the earliest and biggest bets by the Trump administration to fight the pandemic.Moderna's vaccine candidate is one of the earliest and biggest bets by the Trump administration to fight the pandemic.

Chinese-backed hackers 'targeted COVID-19 vaccine firm Moderna' | USA News | Al Jazeera

You have been blocked

Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5 million.Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5 million.

Brigham president resigns from Moderna board after conflict of interest questions raised - The Boston Globe

The vaccines might face heightened scrutiny due to the lack of transparency and opaque regulatory systems in both China and Russia compared to others.The vaccines might face heightened scrutiny due to the lack of transparency and opaque regulatory systems in both China and Russia compared to others.

Reuters reported on Thursday citing an anonymous US security official that Beijing-linked hackers attempted to steal data from US coronavirus vaccine research developerReuters reported on Thursday citing an anonymous US security official that Beijing-linked hackers attempted to steal data from US coronavirus vaccine research

China rejects accusations of hacking US vaccine developer moderna

Two Wilmington companies are supporting a phase 3 clinical study aimed at developing a vaccine for tTwo Wilmington companies are supporting a phase 3 clinical study aimed at developing a vaccine for the new coronavirus. Wilmington-based PPD Inc. is one of those companies involved in Moderna Inc.'s phase 3 study of its mRNA vaccine candidate against COVID-19, according to a news release. Cambridge, Massachusetts-based Moderna Inc. and the National Institute of Allergy and Infection Diseases (NIAID), part of the National Institutes of Health, announced this week that the phase 3 trial for the vaccine, known as mRNA-1273, has started. NIAID and the federal government's Biomedical Advanced Research and Development Authority (BARDA) are providing funding for the trial, stated the release. The biotechnology company is working with the NIAID and BARDA to develop the study, which is being supported by the government's Operation Warp Speed, a multi-agency initiative consisting of private and public partners that aims to deliver a safe and effective vaccine for COVID-19 by January 2021. “Congratulations to Moderna on this important milestone. The world is eager for solutions, and we are pleased to support Moderna in progressing its vaccine candidate," David Simmons, PPD’s chairman and CEO, said this week. "The depth of our relationship with Moderna has enabled us to jointly expedite strategy development from the early days of the pandemic and accelerate its COVID-19 program execution.” On top of PPD's work to support Moderna's phase 3 study, it has also supported the phase 2 study, which completed the enrollment of 600 people at eight research sites within a month, according to the release. "PPD has contributed an array of clinical development and laboratory services, including strategic expertise to the study design, patient-enrollment epidemiology modeling and biostatistics," stated the release. The phase 3 trial is expected to include 30,000 participants and take place at 100 clinical research sites selected by Moderna, according to the release. "The primary endpoint will be the prevention of symptomatic COVID-19 disease. Key secondary endpoints include prevention of severe COVID-19 disease (as defined by the need for hospitalization) and prevention of infection by SARS-CoV-2 regardless of symptomology. SARS-CoV-2 is the virus that causes COVID-19," stated the release. Moderna "is partnering closely with those sites to ensure that volunteers at increased risk for COVID-19 disease are enrolled in the study" and is working with local communities to reach a diverse population, officials said in the release. Wilmington is one of those sites, said Phil Dattilo, president of Wilmington-based Trial Management Associates LLC, a clinical management firm. Trial Management Associates (TMA) is taking part in Moderna's phase 3 study by working with Bart Williams and Will Jones, two physicians at Wrightsville Family Practice, to conduct phase 3 clinical trials in Wilmington. The company announced in June that it would be part of a phase 3 trial for a potential coronavirus vaccine, but was unable at the time to confirm what the firm it was involved with.  ​“Drs. Williams and Jones are very excited to begin the Phase 3 trial of Moderna’s vaccine here in Wilmington this coming week,” Dattilo said in an email Thursday. “We are continuing to accept people who are interested in participating … We appreciate all of our current volunteers’ patience as we work diligently to schedule the large volume of volunteers for their initial visit.” Those in the area who would like to participate in the phase 3 trial can email TMA at covidvaccine@trialmgt.com. The group was also selected by Moderna earlier this year to conduct a phase 2 trial for the potential vaccine. Wilmington was one of 10 sites selected by Moderna for the phase 2 trial, which wrapped up earlier this year. Another company, Pfizer, announced Monday that it had also begun a late-stage coronavirus vaccine study, according to news reports.

Two Wilmington firms involved in Moderna's phase 3 COVID vaccine study | WilmingtonBiz

Moderna Inc. is one of the frontrunner in the world's race to find a Covid vaccine, and the Trump administration has invested nearly half a billion dollars in its development.Moderna Inc. is one of the frontrunner in the world's race to find a Covid vaccine, and the Trump administration has invested nearly half a billion dollars in its development.

China-backed hackers targeted US biotech firm Moderna for Covid vaccine research, says report

Moderna Inc. is one of the frontrunner in the world's race to find a Covid vaccine, and the Trump administration has invested nearly half a billion dollars in its development.Moderna Inc. is one of the frontrunner in the world's race to find a Covid vaccine, and the Trump administration has invested nearly half a billion dollars in its development.

China-backed hackers targeted US biotech firm Moderna for Covid vaccine research, says report

A U.S. security official says hackers linked to the Chinese government targeted a U.S. biotech firm researching coronavirus vaccines.A U.S. security official says hackers linked to the Chinese government targeted a U.S. biotech firm researching coronavirus vaccines.

U.S. Says Chinese Hackers Targeted Firm Making Coronavirus Vaccine

Immunity.Immunity.

Question: If a Coronavirus Vaccine Were Approved and Produced Tomorrow, Would You Take It?

Immunity.Immunity.

Question: If a Coronavirus Vaccine Were Approved and Produced Tomorrow, Would You Take It?

While US infectious diseases expert Anthony Fauci said long-term effects of exposure to Covid are yet unknown, others said human challenge trials could quicken vaccine search.While US infectious diseases expert Anthony Fauci said long-term effects of exposure to Covid are yet unknown, others said human challenge trials could quicken vaccine search.

Human challenge trials for Covid vaccine unnecessary, unethical — Fauci at ICMR symposium

While US infectious diseases expert Anthony Fauci said long-term effects of exposure to Covid are yet unknown, others said human challenge trials could quicken vaccine search.While US infectious diseases expert Anthony Fauci said long-term effects of exposure to Covid are yet unknown, others said human challenge trials could quicken vaccine search.

Human challenge trials for Covid vaccine unnecessary, unethical — Fauci at ICMR symposium

Moderna, which is based in Massachusetts and announced its COVID-19 vaccine candidate in January, confirmed to Reuters that the company had been in co..Moderna, which is based in Massachusetts and announced its COVID-19 vaccine candidate in January, confirmed to Reuters that the company had been in co..

Chinese-backed hackers targeted Covid-19 vaccine firm Moderna, Health News, ET HealthWorld